Glucagon-like peptide-1 (GLP-1) protects endothelial NO synthase function against the detrimental effects of hyperglycemia, potentially reducing TNF-α-induced expression of PAI-1 [126,127]. This evidence concerns the gene GCG and Hyperglycemia.